Catherine Burzik M.'s most recent trade in Becton, Dickinson And Co. was a trade of 930 Common Stock done . Disclosure was reported to the exchange on Jan. 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson & Company | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 930 | 14,264 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.23 per share. | 08 Apr 2024 | 47,486 | 112,803 (0%) | 0% | 14.2 | 675,726 | Common Stock |
| Becton, Dickinson & Company | Catherine Burzik M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 900 | 13,242 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2023 | 3,589 | 37,949 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2023 | 848 | 13,425 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 33,056 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 19,545 (0%) | 0% | - | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 8,844 | 17,443 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 820 | 12,499 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Purchase of securities on an exchange or from another person at price $ 30.27 per share. | 19 Nov 2021 | 1,660 | 7,947 (0%) | 0% | 30.3 | 50,248 | Common Stock |
| Haemonetics Corp | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 16,815 (0%) | 0% | - | Common Stock | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 21,361 | 21,361 | - | - | Stock Option (right to buy) | |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2021 | 5,976 | 5,976 (0%) | 0% | 0 | Common Stock | |
| Becton, Dickinson & Company | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2021 | 829 | 11,661 (0%) | 0% | 0 | Common Stock |